Prevalence, risk factors, and management of asthma in China: a national cross-sectional study
2019 · The Lancet · 737 citations
https://doi.org/10.1016/s0140-6736(19)31147-x
W
Wen Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
156
Papers
3.8K
Citations
30
h-index
64
i10-index
Wen Li is an academic researcher from Central South University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Asthma and respiratory diseases & COVID-19 Clinical Research Studies. The author has an h-index of 30, co-authored 133 publications.
ORCID: 0000-0002-8981-8380Papers by this author
worksLong-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis
2015 · Scientific Reports · 102 citations
https://doi.org/10.1038/srep08191
Myosin Light Chain Kinase Is Necessary for Tonic Airway Smooth Muscle Contraction
2009 · Journal of Biological Chemistry · 76 citations
https://doi.org/10.1074/jbc.m109.062836
Genome-wide identification and characterization of JAZ gene family in upland cotton (Gossypium hirsutum)
2017 · Scientific Reports · 50 citations
https://doi.org/10.1038/s41598-017-03155-4
The Scap-SREBP1-S1P/S2P lipogenesis signal orchestrates the homeostasis and spatiotemporal activation of NF-κB
2023 · Cell Reports · 34 citations
https://doi.org/10.1016/j.celrep.2023.112586
A new antagonist for CCR4 attenuates allergic lung inflammation in a mouse model of asthma
2017 · Scientific Reports · 32 citations
https://doi.org/10.1038/s41598-017-11868-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat